Neurotrack
Neurotrack is a digital health company that sells an FDA-registered 3-minute cognitive screening test and a Memory Health Program to healthcare providers, Medicare Advantage plans, and long-term care insurers for early detection of Alzheimer's and related dementias.
- Company typePrivate
- Founded2012
- HeadquartersRedwood City, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Neurotrack does
Neurotrack is a Redwood City-based digital health company founded in 2012 that develops FDA-registered, cloud-based cognitive screening and brain health solutions targeting early detection of mild cognitive impairment, Alzheimer's disease, and related dementias. Its core product is a 3-minute digital cognitive screening test (Class II medical device) that uses proprietary machine-learning algorithms trained on large datasets to provide age-specific, DSM-5-aligned scoring across any device, with integration into all major electronic health record systems. The company complements the screener with a Memory Health Program — an app-based digital therapeutic combining board-certified health coaching with multi-domain lifestyle interventions (nutrition, physical activity, vascular health, sleep, stress, cognitive training) — plus a patient education library of 100+ brain-health articles. Original eye-tracking technology developed at Emory University remains in research applications only and is not part of the current clinical offering.
Neurotrack monetizes through quote-based, annual enterprise subscriptions to healthcare organizations, with three primary customer segments: (1) healthcare providers and health systems (e.g., Sutter Health serving 3.5 million patients, Providence, Stanford Medicine, Desert Oasis Healthcare) using the platform in primary care, home health, and specialty settings; (2) Medicare Advantage plans and payers using cognitive screening for population health management, Star Ratings, and HEDIS/CMS compliance; and (3) life and long-term care insurers (e.g., Nationwide, Dai-ichi Life, Hannover Re) for underwriting and policyholder screening. Go-to-market is enterprise field sales targeting large health systems and payers, with deployments measured in weeks. The company holds 11 patents on its assessment technology and reports 375+ peer-reviewed publications, 25 core studies, and SOC 2, HIPAA, and ISO 13485 certifications. Leadership is anchored by co-founder and CEO Elli Kaplan, with a Chief Growth Officer (hired May 2023), CTO, CSO, and VP-level teams in Strategic Partnerships, Marketing, and Customer Success. Total disclosed funding since 2013 is approximately $47M+ across multiple rounds including a $21M raise in 2019 (Khosla Ventures-led) and a $10M raise in November 2022, plus a $3.3M NIA SBIR grant.
Neurotrack firmographics
Firmographics- Name
- Neurotrack
- Legal name
- Neurotrack Technologies, Inc.
- Website
- https://neurotrack.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Neurotrack is a digital health company that sells an FDA-registered 3-minute cognitive screening test and a Memory Health Program to healthcare providers, Medicare Advantage plans, and long-term care insurers for early detection of Alzheimer's and related dementias.
- Ownership category
- akta.pro rank
Neurotrack industry classification
Industry- Product category
- Digital Cognitive Health Screening
- NAICS
- Residential Intellectual and Developmental Disability Facilities (623210)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- Neurology Telemedicine Platforms (HLALAGAC), Behavioral Health & Psychiatry Virtual Care (Payer Network) (HLALACAC)
Keywords
Where Neurotrack is headquartered
LocationHeadquarters
- HQ city
- Redwood City
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Neurotrack business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Cognitive Assessment Licensing/SaaS: Digital cognitive screening solutions licensed to healthcare organizations including health systems, providers, and payers. The company provides technology that can be administered in-clinic or remotely, with pricing likely based on volume or subscription model.
- Health Coaching Services: 1:1 support from board-certified health coaches integrated into the cognitive health program. Partnership with Fortune 100 long-term care insurance provider making services available to policy holders.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise healthcare organizations |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Neurotrack product offering
Product offeringCore offering
Neurotrack develops and sells a 3-minute digital cognitive screening test (FDA-registered Class II medical device) and a Memory Health Program (digital therapeutic with 1:1 health coaching) used by healthcare providers, health systems, payers, and insurers for early detection of mild cognitive impairment and dementia. The platform integrates with all major EHR systems and supports Annual Wellness Visit compliance and population-wide cognitive screening.
Product overview
Neurotrack offers a unified cognitive health platform centered on a 3-minute digital cognitive screening test for clinical detection of mild cognitive impairment and dementia, paired with a Memory Health Program that delivers multi-domain lifestyle interventions and 1:1 health coaching. A patient education library of 100+ articles supports behavior change across modifiable risk factors. The company's original eye-tracking technology, developed by co-founders at Emory University, is now reserved for research applications. All clinical products are FDA-registered, work on any device, integrate with EHR systems, and are SOC 2 and HIPAA compliant.
Differentiator
Problem solved
Functional benefit
Products and services
- Neurotrack 3-Minute Cognitive Screening Test A rapid digital cognitive screening tool that delivers objective, DSM-5-aligned cognitive baseline assessment in approximately 3 minutes for healthcare providers and payers in primary care and Annual Wellness Visit settings. FDA-registered Class II medical device that integrates with all major EHR systems and works on any device.
- Neurotrack Memory Health Program An app-based digital therapeutic providing multi-domain lifestyle interventions and 1:1 health coaching to address modifiable Alzheimer's risk factors including physical activity, nutrition, vascular health, sleep, stress, social engagement, and cognitive training. Includes multi-modal neuropsychological assessments for baseline and longitudinal cognitive health measurement; intended for individuals at risk for cognitive decline and their healthcare providers.
Quantifiable outcome
- 90% of staff say Neurotrack's screener is easy to use
- +4 more outcomes
Companies that use Neurotrack
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Neurotrack technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
Neurotrack partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Sutter HealthcoreSutter Health, serving 3.5 million patients and consistently ranked among top U.S. health systems, is using Neurotrack's cognitive screening for innovative new workflows. This is a flagship partnership demonstrating deployment at a major health system level.
- NationwidecoreFortune 100 provider of long-term care insurance partnered to make Neurotrack's cognitive assessment and health coaching services available to 30,000+ policy holders. Three-minute online cognitive screening for underwriting.
- Dai-ichi LifecorePartnership with Japan's second largest life insurance company to sell a dementia insurance product allowing members to take Neurotrack's five-minute Imprint Memory Assessment test via eye-tracking program. Early deployment December 2018.
- Desert Oasis HealthcarecoreDesert Oasis Healthcare, a California healthcare provider, implemented Neurotrack's screening program that's closing gaps and connecting patients to care. Features testimonial from Brian Hodgkins, PharmD, EVP of Clinical Operations.
- University of ArkansascoreResearch collaboration with Dr. Michelle Gray at the University of Arkansas Exercise Science Research Center for NIA-funded study on health education and coaching reducing Alzheimer's risk factors. Study published in GeroScience.
- Hannover ReminorMajor reinsurance company partner shown in commercial and research partners section of website.
- Providence Health SystemcoreMajor health system partner using Neurotrack's cognitive screening solutions, shown in commercial and research partners section.
- Alzheimer's Drug Discovery Foundation (ADDF)minorNon-profit foundation partner shown in commercial and research partners section, focused on accelerating Alzheimer's therapeutics development.
- Stanford MedicineminorAcademic medical center partner shown in commercial and research partners section.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Neurotrack competitors and assessment
Company assessmentDirect peers
- Linus Health: Linus Health is a Boston-based digital health company offering digital cognitive assessments (e.g., DCTclock, Linus Screening) to health systems and payers — the same primary care and MA customer base Neurotrack serves, with overlapping FDA-cleared digital cognitive screening products.
- Cognivue: Cognivue makes FDA-cleared computerized cognitive assessment devices used in primary care and specialty clinics, overlapping directly with Neurotrack's FDA-registered Class II cognitive screener and the same provider buyer persona.
- Creyos (formerly Cambridge Brain Sciences): Creyos offers online cognitive assessments and a digital health platform sold to providers, payers, and researchers, competing for the same primary care cognitive screening workflow and population-health use cases as Neurotrack.
- BrainCheck: BrainCheck provides digital cognitive assessment and care coordination tools used by primary care providers and neurologists. It directly competes with Neurotrack's 3-minute cognitive screener in the same clinical workflow and reimbursement context.
Broad incumbents
- Biogen: Biogen markets Leqembi, an early-stage Alzheimer's therapeutic whose uptake directly increases demand for early cognitive screening — making it an adjacent incumbent whose commercial priorities shape the market Neurotrack serves.
- Quest Diagnostics: Quest Diagnostics is a large clinical laboratory network now offering AD-Detect blood-based Alzheimer's tests; as a broad incumbent it competes with Neurotrack at the 'how to detect cognitive decline' clinical workflow level for primary care and payer customers.
- Signant Health: Signant Health is a large clinical-trial technology provider that historically used Neurotrack-style cognitive assessments (and competes with similar offerings) for CNS trials, representing a broader incumbent in the cognitive assessment ecosystem.
Emerging players
- Altoida: Altoida develops FDA-cleared digital cognitive assessments using augmented reality and digital biomarkers, with a similar aim of detecting early signs of cognitive decline. It is a more research-stage but directly comparable peer in digital cognitive screening.
- C2N Diagnostics: C2N Diagnostics provides blood-based biomarker tests (e.g., PrecivityAD) for Alzheimer's detection, representing a complementary rather than overlapping modality that competes for the same 'early Alzheimer's detection' clinical decision point as Neurotrack's screener.
- Savonix: Savonix offers a digital neurocognitive assessment platform delivered via mobile devices, targeting similar healthcare, payer, and population-health customers as Neurotrack for cognitive screening and brain health monitoring.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Neurotrack social profiles
Digital presenceNeurotrack compliance and trust
Trust signalCompliance3 records
Neurotrack financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neurotrack leadership team
Management profileNumber of profiles
Profiles13 records
Neurotrack funding detail
Funding detailFunding overview
Funding rounds9 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neurotrack M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neurotrack
What does Neurotrack do?
Neurotrack develops and sells a 3-minute digital cognitive screening test (FDA-registered Class II medical device) and a Memory Health Program (digital therapeutic with 1:1 health coaching) used by healthcare providers, health systems, payers, and insurers for early detection of mild cognitive impairment and dementia. The platform integrates with all major EHR systems and supports Annual Wellness Visit compliance and population-wide cognitive screening.
Is Neurotrack a public or private company?
Neurotrack is a private company. It is classified as venture growth investor backed and is currently operating.
When was Neurotrack founded?
Neurotrack was founded in 2012. It employs 11 to 50 people.
Where is Neurotrack based?
Neurotrack is headquartered in Redwood City, United States, in the North America region.
How does Neurotrack make money?
Two revenue lines are on record. Cognitive Assessment Licensing/SaaS are the primary driver. The others are health Coaching Services.
Who are Neurotrack's main competitors?
Direct peers on record are Linus Health, Cognivue, Creyos (formerly Cambridge Brain Sciences) and BrainCheck. Broad incumbents are Biogen, Quest Diagnostics and Signant Health. Emerging players are Altoida, C2N Diagnostics and Savonix.
Does Neurotrack have an API?
No public API is recorded for Neurotrack.
What industry is Neurotrack in?
Neurotrack's product category is Digital Cognitive Health Screening. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAGAC, Neurology Telemedicine Platforms. Its NAICS code is 623210 and its SIC code is 8071.